speb/financial-data huggingface dataset:
Financial ratios for HCC.NS — annual report dated 2025-03-31
Total revenue: 655058452.1861117
Gross profit: 215704933.36450782
Operating income: 73622866.49520692
Net income: 13166939.443535186
Capital expenditures: 718961.8891746551
Operating cash flow: 15620762.216506897
Depreciation & amortization: 19169978.957213
Net tangible assets: 99303249.94154781
Owner earnings: 31617956.51157353
Return on net tangible assets (%): 31.839800339046896
Capex to operating income (%): 0.9765469933467772
Buffett classification: The Great
Stock price: 0.30166880616174585
P/E ratio: 60.01484296567847
Shares outstanding: 2619468062
Book value: 105880289.9228431
P/B ratio: 7.4632568877380665
Market cap (USD): 790211803.0423621
Debt to equity: 1.8539361819587061
Current ratio: 1.2086850654392534
Quick ratio: 1.182182219489116
Effective tax rate (%): 78.47121339551954
Interest coverage ratio: 1.0501417375354345
COGS to revenue (%): 67.07088769793891
SG&A to revenue (%): 2.9824908938727948
Free cash flow (dilution-adjusted): 13524666.822539162
Buyback yield (%): 0
Retained earnings: -362292494.73930323
Inventory turnover: 29.361171875
Receivables turnover: 2.3463224671817096
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.32604199272094
FCF margin (%): 2.064650380039155
Revenue growth (%): -17.58661187892379
Rule of 40 score: -15.521961498884636
Financial ratios for HCC.NS — quarterly report dated 2025-06-30
Total revenue: 127700678.68008426
Gross profit: 43793587.64334192
Operating income: 19647788.439035807
Net income: 5936110.461034402
Capital expenditures: 0
Depreciation & amortization: 1352679.616194711
Owner earnings: 7288790.077229113
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.3574771823075123
P/E ratio: 78.48990757303243
Shares outstanding: 2619468062
Market cap (USD): 936400061.94828
Effective tax rate (%): 30.810147299509
Interest coverage ratio: 1.3772145669291338
COGS to revenue (%): 65.70606507655796
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -20.4810653396345
Rule of 40 score: -20.4810653396345
Financial ratios for HCC.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.30541149943630214
P/E ratio: 67.05804327918034
Shares outstanding: 2619468062
Market cap (USD): 800015668.5409244
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCC.NS — quarterly report dated 2025-12-31
Total revenue: 103076751.6987858
Gross profit: 39073187.03353013
Operating income: 6938843.711707698
Net income: 898964.0191600758
Capital expenditures: 0
Depreciation & amortization: 545839.3672719172
Owner earnings: 1444803.386431993
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.21098362481898186
P/E ratio: 31.824863802185423
Shares outstanding: 2619468062
Market cap (USD): 552664866.8183135
Effective tax rate (%): 47.56335282651072
Interest coverage ratio: 0.5066287108580724
COGS to revenue (%): 62.093113733627284
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HVY.AX — annual report dated 2022-06-30
Operating income: -708701.3793103448
Net income: -722706.2068965518
Capital expenditures: 44301.379310344826
Depreciation & amortization: 1410.344827586207
Net tangible assets: 3026960.6896551726
Owner earnings: -765597.2413793104
Return on net tangible assets (%): -25.292606012221658
Buffett classification: The Gruesome
Stock price: 0.1310344827586207
Shares outstanding: 71783592
Book value: 2996964.1379310344
P/B ratio: 3.138551352426065
Market cap (USD): 9406125.848275863
Debt to equity: 0
Current ratio: 19.362648856795307
Quick ratio: 19.362648856795307
Free cash flow (dilution-adjusted): -1905997.9310344828
Buyback yield (%): 3.589362990097411
Retained earnings: -3399175.8620689656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.647309300123943
Rule of 40 score: 0
Financial ratios for HVY.AX — annual report dated 2023-06-30
Operating income: -794017.880794702
Net income: -775978.1456953642
Capital expenditures: 22006.62251655629
Depreciation & amortization: 13316.556291390729
Net tangible assets: 2322657.6158940396
Owner earnings: -784668.2119205298
Return on net tangible assets (%): -33.7832062096029
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
Shares outstanding: 71783592
Book value: 2293852.9801324503
P/B ratio: 2.072443310916189
Market cap (USD): 4753880.264900663
Debt to equity: 0
Current ratio: 5.417857048904322
Quick ratio: 5.417857048904322
Interest coverage ratio: -12110.777777777777
Free cash flow (dilution-adjusted): -1382103.311258278
Buyback yield (%): 0.019154795151515962
Retained earnings: -4040087.417218543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.61502928356177
Rule of 40 score: 0
Financial ratios for HVY.AX — annual report dated 2024-06-30
Operating income: -783334
Net income: -764608
Capital expenditures: 4484.666666666667
Depreciation & amortization: 57076.666666666664
Net tangible assets: 2170731.3333333335
Owner earnings: -712016
Return on net tangible assets (%): -32.80074272971598
Buffett classification: The Gruesome
Stock price: 0.04666666666666667
Shares outstanding: 71783592
Book value: 2141734.666666667
P/B ratio: 1.5641064283717683
Market cap (USD): 3349900.96
Debt to equity: 0.2656398147047159
Current ratio: 0.952439233057977
Quick ratio: 0.952439233057977
Interest coverage ratio: -97.22000661922887
Free cash flow (dilution-adjusted): -921854
Buyback yield (%): 0.6533725502539435
Retained earnings: -4831629.333333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.512998266897743
Rule of 40 score: 0
Financial ratios for HWC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.14
Shares outstanding: 80471000
Market cap (USD): 3551989940
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HWC — annual report dated 2022-12-31
Total revenue: 1378393000
Net income: 524089000
Capital expenditures: 29083000
Operating cash flow: 842021000
Depreciation & amortization: 45615000
Net tangible assets: 2430982000
Owner earnings: 540621000
Return on net tangible assets (%): 22.238790743822868
Buffett classification: The Gruesome
Stock price: 43.6
P/E ratio: 6.694541575953703
Shares outstanding: 80471000
Book value: 3342628000
P/B ratio: 1.049633880886536
Market cap (USD): 3508535600
Debt to equity: 0.6670709393925977
Effective tax rate (%): 20.495725095419267
COGS to revenue (%): 0
SG&A to revenue (%): 33.34419138808743
Free cash flow (dilution-adjusted): 789387000
Buyback yield (%): 1.6785350560501653
Retained earnings: 2088413000
Receivables turnover: 8.25924106153118
Capitalized R&D asset: 0
FCF margin (%): 57.268645444368914
Rule of 40 score: 57.268645444368914
Financial ratios for HWC — annual report dated 2023-12-31
Total revenue: 1366691000
Net income: 392602000
Capital expenditures: 8105000
Operating cash flow: 495249000
Depreciation & amortization: 46276000
Net tangible assets: 2903571000
Owner earnings: 430773000
Return on net tangible assets (%): 14.835972669516263
Buffett classification: The Gruesome
Stock price: 45.04
P/E ratio: 9.231776302718785
Shares outstanding: 80471000
Book value: 3803661000
P/B ratio: 0.9528750958615922
Market cap (USD): 3624413840
Debt to equity: 0.39876424318570974
Effective tax rate (%): 19.898067443606568
COGS to revenue (%): 0
SG&A to revenue (%): 37.372602878046315
Free cash flow (dilution-adjusted): 445572000
Buyback yield (%): 0
Retained earnings: 2375604000
Receivables turnover: 6.358476784218852
Capitalized R&D asset: 0
FCF margin (%): 32.602248789228874
Revenue growth (%): -0.8489596218204822
Rule of 40 score: 31.75328916740839
Financial ratios for HWC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.28
Shares outstanding: 80471000
Market cap (USD): 4207023880
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HWC — annual report dated 2024-12-31
Total revenue: 1438230000
Net income: 460815000
Capital expenditures: 4093000
Operating cash flow: 625742000
Depreciation & amortization: 41714000
Net tangible assets: 3236959000
Owner earnings: 498436000
Return on net tangible assets (%): 15.398279681639465
Buffett classification: The Gruesome
Stock price: 52.28
P/E ratio: 9.129528943285267
Shares outstanding: 80471000
Book value: 4127636000
P/B ratio: 1.0192332560332356
Market cap (USD): 4207023880
Debt to equity: 0.2343656272016234
Effective tax rate (%): 19.71486463648987
COGS to revenue (%): 0
SG&A to revenue (%): 33.984272334744794
Free cash flow (dilution-adjusted): 592802000
Buyback yield (%): 0.8958827207798022
Retained earnings: 2704606000
Receivables turnover: 8.853697274137549
Capitalized R&D asset: 0
FCF margin (%): 41.217468694158796
Revenue growth (%): 5.234467776549344
Rule of 40 score: 46.45193647070814
Financial ratios for HWC — quarterly report dated 2025-03-31
Total revenue: 362839000
Net income: 119504000
Capital expenditures: 3951000
Operating cash flow: 104182000
Depreciation & amortization: 9905000
Net tangible assets: 3390109000
Owner earnings: 125458000
Return on net tangible assets (%): 3.7007069684190097
Buffett classification: The Gruesome
Stock price: 50.52
P/E ratio: 8.504725615878966
Shares outstanding: 80471000
Book value: 4278672000
P/B ratio: 0.9501534401328263
Market cap (USD): 4065394920.0000005
Debt to equity: 0.07599180306412831
Effective tax rate (%): 19.890062007709066
COGS to revenue (%): 0
SG&A to revenue (%): 32.66021568794975
Free cash flow (dilution-adjusted): 94310000
Buyback yield (%): 0.51033172442691
Retained earnings: 2784657000
Receivables turnover: 2.582006176792907
Capitalized R&D asset: 0
FCF margin (%): 25.99224449411447
Rule of 40 score: 25.99224449411447
Financial ratios for HWC — quarterly report dated 2025-06-30
Total revenue: 374447000
Net income: 113531000
Capital expenditures: 3807000
Operating cash flow: 125803000
Depreciation & amortization: 9753000
Net tangible assets: 3367628000
Owner earnings: 119477000
Return on net tangible assets (%): 3.5478087247166257
Buffett classification: The Gruesome
Stock price: 55.76
P/E ratio: 9.880699896944448
Shares outstanding: 80471000
Book value: 4365419000
P/B ratio: 1.0278653572543666
Market cap (USD): 4487062960
Debt to equity: 0.19441501491609398
Effective tax rate (%): 21.474764661534522
COGS to revenue (%): 0
SG&A to revenue (%): 32.15808912876856
Free cash flow (dilution-adjusted): 115953000
Buyback yield (%): 0.8787485344310836
Retained earnings: 2859038000
Receivables turnover: 2.6250087629516425
Capitalized R&D asset: 0
FCF margin (%): 30.966465214035633
Revenue growth (%): 3.1992150788641793
Rule of 40 score: 34.165680292899815
Financial ratios for HWC — quarterly report dated 2025-09-30
Total revenue: 383826000
Net income: 127466000
Capital expenditures: 3820000
Operating cash flow: 158787000
Depreciation & amortization: 8801000
Net tangible assets: 3479383000
Owner earnings: 132447000
Return on net tangible assets (%): 3.806623185777478
Buffett classification: The Gruesome
Stock price: 61.25
P/E ratio: 13.672219355840898
Shares outstanding: 80471000
Book value: 4474479000
P/B ratio: 1.1015469622273342
Market cap (USD): 4928848750
Debt to equity: 0.3651285434572383
Effective tax rate (%): 20.500202700595626
COGS to revenue (%): 0
SG&A to revenue (%): 32.86775778608015
Free cash flow (dilution-adjusted): 148527000
Buyback yield (%): 0.8128673049664995
Retained earnings: 2947752000
Receivables turnover: 2.702524203485302
Capitalized R&D asset: 0
FCF margin (%): 38.69644057463538
Revenue growth (%): 2.504760353267619
Rule of 40 score: 41.201200927903
Financial ratios for HWC — quarterly report dated 2025-12-31
Total revenue: 387988000
Net income: 125572000
Capital expenditures: 7142000
Operating cash flow: 153006000
Depreciation & amortization: 8808000
Net tangible assets: 3467642000
Owner earnings: 127238000
Return on net tangible assets (%): 3.6692945811591855
Buffett classification: The Gruesome
Stock price: 62.74
P/E ratio: 10.386815437187419
Shares outstanding: 80471000
Book value: 4460117000
P/B ratio: 1.1319771521688782
Market cap (USD): 5048750540
Debt to equity: 0.3000378689617335
Effective tax rate (%): 20.677674882821876
COGS to revenue (%): 0
SG&A to revenue (%): 32.577811684897476
Free cash flow (dilution-adjusted): 139824000
Buyback yield (%): 2.9043225415530234
Retained earnings: 3035636000
Receivables turnover: 2.4022091101025924
Capitalized R&D asset: 0
FCF margin (%): 36.03822798643257
Revenue growth (%): 1.0843455107262145
Rule of 40 score: 37.12257349715878
Financial ratios for HWC — annual report dated 2025-12-31
Total revenue: 1509100000
Net income: 486073000
Capital expenditures: 18720000
Operating cash flow: 541778000
Depreciation & amortization: 37267000
Net tangible assets: 3467642000
Owner earnings: 504620000
Return on net tangible assets (%): 14.552251933734798
Buffett classification: The Gruesome
Stock price: 62.74
P/E ratio: 10.386815437187419
Shares outstanding: 80471000
Book value: 4460117000
P/B ratio: 1.1319771521688782
Market cap (USD): 5048750540
Debt to equity: 0.3000378689617335
Effective tax rate (%): 20.627536149054123
COGS to revenue (%): 0
SG&A to revenue (%): 32.56722549864157
Free cash flow (dilution-adjusted): 498614000
Buyback yield (%): 4.8898038840318705
Retained earnings: 3035636000
Receivables turnover: 9.34352033582436
Capitalized R&D asset: 0
FCF margin (%): 33.04048770790538
Revenue growth (%): 4.927584600515912
Rule of 40 score: 37.96807230842129
Financial ratios for ICHR — annual report dated 2021-12-31
Capital expenditures: 504000
Buffett classification: The Gruesome
Stock price: 46.03
Shares outstanding: 34867053
Market cap (USD): 1604930449.5900002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICHR — annual report dated 2022-12-31
Total revenue: 1280069000
Gross profit: 211864000
Operating income: 85823000
Net income: 72804000
Capital expenditures: 0
Operating cash flow: 31453000
Depreciation & amortization: 35100000
Net tangible assets: 180072000
Owner earnings: 107904000
Return on net tangible assets (%): 59.92269758763161
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.82
P/E ratio: 12.84454647354541
Shares outstanding: 34867053
Book value: 587496000
P/B ratio: 1.591728899362719
Market cap (USD): 935134361.46
Debt to equity: 0.5816924710976755
Current ratio: 3.0876891251533447
Quick ratio: 1.3818944988333774
Effective tax rate (%): 3.3532457188371168
Interest coverage ratio: 7.762572358900145
COGS to revenue (%): 83.44901720141648
R&D to revenue (%): 1.5283551121072378
SG&A to revenue (%): 6.9193145057024275
Free cash flow (dilution-adjusted): -11904000
Buyback yield (%): 0
Retained earnings: 247656000
Inventory turnover: 3.765793555665233
Receivables turnover: 9.390108640634972
Capitalized R&D asset: 19564000
ROCI (R&D-adjusted, %): 10.551140822513503
FCF margin (%): -0.9299498698898262
Rule of 40 score: -0.9299498698898262
Financial ratios for ICHR — annual report dated 2023-12-31
Total revenue: 811120000
Gross profit: 103396000
Operating income: -10895000
Net income: -42985000
Capital expenditures: 0
Operating cash flow: 57632000
Depreciation & amortization: 34577000
Net tangible assets: 171987000
Owner earnings: -8408000
Return on net tangible assets (%): -4.888741590934199
Buffett classification: The Gruesome
Stock price: 33.63
Shares outstanding: 34867053
Book value: 564677000
P/B ratio: 2.0765481724773633
Market cap (USD): 1172578992.39
Debt to equity: 0.5070739555533518
Current ratio: 4.05574867120713
Quick ratio: 1.571108102099796
Interest coverage ratio: -0.5622065122039321
COGS to revenue (%): 87.25268764177927
R&D to revenue (%): 2.493219252391755
SG&A to revenue (%): 9.78079692277345
Free cash flow (dilution-adjusted): 24798000
Buyback yield (%): 0
Retained earnings: 204671000
Inventory turnover: 2.8782723630965696
Receivables turnover: 12.156892132911677
Capitalized R&D asset: 33330880
ROCI (R&D-adjusted, %): -0.4507457036407376
Rosenberg metric: -5.544264976487426
FCF margin (%): 3.057254167077621
Revenue growth (%): -36.63466578754739
Rule of 40 score: -33.57741162046977
Financial ratios for ICHR — annual report dated 2024-12-31
Total revenue: 849040000
Gross profit: 103334000
Operating income: -7640000
Net income: -20820000
Capital expenditures: 17636000
Operating cash flow: 27880000
Depreciation & amortization: 30744000
Net tangible assets: 314218000
Owner earnings: -7712000
Return on net tangible assets (%): -2.4543469820315833
Buffett classification: The Gruesome
Stock price: 32.22
Shares outstanding: 34867053
Book value: 698336000
P/B ratio: 1.6087047605450673
Market cap (USD): 1123416447.6599998
Debt to equity: 0.24945871328414976
Current ratio: 3.3361833861575882
Quick ratio: 1.4927249944718803
Interest coverage ratio: -0.824519749622275
COGS to revenue (%): 87.82931310656743
R&D to revenue (%): 2.711061905210591
SG&A to revenue (%): 9.349853952699519
Free cash flow (dilution-adjusted): -5332000
Buyback yield (%): 0
Retained earnings: 183851000
Inventory turnover: 2.9816075041383114
Receivables turnover: 9.802006488183885
Capitalized R&D asset: 43023530
ROCI (R&D-adjusted, %): -0.6154493423114734
Rosenberg metric: -0.0030658161499282997
FCF margin (%): -0.6280033920663337
Revenue growth (%): 4.675017260084821
Rule of 40 score: 4.047013868018487
Financial ratios for ICHR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.22
Shares outstanding: 34867053
Market cap (USD): 1123416447.6599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICHR — quarterly report dated 2025-03-31
Total revenue: 244465000
Gross profit: 28522000
Operating income: -1172000
Net income: -4559000
Capital expenditures: 18481000
Operating cash flow: 18977000
Depreciation & amortization: 8058000
Net tangible assets: 318321000
Owner earnings: -14982000
Return on net tangible assets (%): -4.706569783331919
Buffett classification: The Gruesome
Stock price: 22.61
Shares outstanding: 34867053
Book value: 700361000
P/B ratio: 1.1256253108468348
Market cap (USD): 788344068.3299999
Debt to equity: 0.24245353467711653
Current ratio: 3.0878750436487685
Quick ratio: 1.3187300222944478
Interest coverage ratio: -0.7120291616038882
COGS to revenue (%): 88.33289018877957
R&D to revenue (%): 2.402797946536314
SG&A to revenue (%): 8.89370666557585
Free cash flow (dilution-adjusted): -3627000
Buyback yield (%): 0
Retained earnings: 179292000
Inventory turnover: 0.8196611173108019
Receivables turnover: 3.0612078788865373
Capitalized R&D asset: 5874000
ROCI (R&D-adjusted, %): 0.3177503644749534
FCF margin (%): -1.4836479659664983
Rule of 40 score: -1.4836479659664983
Financial ratios for ICHR — quarterly report dated 2025-06-30
Total revenue: 240285000
Gross profit: 27202000
Operating income: -4840000
Net income: -9408000
Capital expenditures: 7291000
Operating cash flow: -7508000
Depreciation & amortization: 7999000
Net tangible assets: 314185000
Owner earnings: -8700000
Return on net tangible assets (%): -2.7690691789869026
Buffett classification: The Gruesome
Stock price: 19.64
Shares outstanding: 34867053
Book value: 694147000
P/B ratio: 0.9865185917680261
Market cap (USD): 684788920.9200001
Debt to equity: 0.2402704326317048
Current ratio: 3.218870718280642
Quick ratio: 1.317629725192966
Interest coverage ratio: -2.9602446483180427
COGS to revenue (%): 88.67927669226128
R&D to revenue (%): 2.3763447572674115
SG&A to revenue (%): 10.093846890151278
Free cash flow (dilution-adjusted): -19026000
Buyback yield (%): 0
Retained earnings: 169884000
Inventory turnover: 0.8215311539751632
Receivables turnover: 2.9730515583821036
Capitalized R&D asset: 9645580
ROCI (R&D-adjusted, %): -0.348522214158908
Rosenberg metric: -0.2247191011235955
FCF margin (%): -7.918097259504339
Revenue growth (%): -1.7098562166363283
Rule of 40 score: -9.627953476140668
Financial ratios for ICHR — quarterly report dated 2025-09-30
Total revenue: 239296000
Gross profit: 11069000
Operating income: -19425000
Net income: -22853000
Capital expenditures: 7148000
Operating cash flow: 9247000
Depreciation & amortization: 7404000
Net tangible assets: 298292000
Owner earnings: -22597000
Return on net tangible assets (%): -7.575462969171149
Buffett classification: The Gruesome
Stock price: 17.52
Shares outstanding: 34867053
Book value: 676177000
P/B ratio: 0.9034184371251905
Market cap (USD): 610870768.56
Debt to equity: 0.24124156840590555
Current ratio: 3.079513008188999
Quick ratio: 1.3280817450539895
Interest coverage ratio: -11.751361161524501
COGS to revenue (%): 95.37434808772399
R&D to revenue (%): 2.4647298742979404
SG&A to revenue (%): 9.410520861192833
Free cash flow (dilution-adjusted): -2122000
Buyback yield (%): 0
Retained earnings: 147031000
Inventory turnover: 0.944335484938762
Receivables turnover: 2.835260663507109
Capitalized R&D asset: 11662120
ROCI (R&D-adjusted, %): -2.3033877298282137
Rosenberg metric: -2.8253940455341504
FCF margin (%): -0.8867678523669431
Revenue growth (%): -0.411594564787648
Rule of 40 score: -1.298362417154591
Financial ratios for ICHR — annual report dated 2025-12-31
Total revenue: 947652000
Gross profit: 87775000
Operating income: -39272000
Net income: -52781000
Capital expenditures: 36169000
Operating cash flow: 29886000
Depreciation & amortization: 33505000
Net tangible assets: 288078000
Owner earnings: -55445000
Return on net tangible assets (%): -19.24652351099355
Buffett classification: The Gruesome
Stock price: 18.43
Shares outstanding: 34867053
Book value: 663886000
P/B ratio: 0.9679369451833598
Market cap (USD): 642599786.79
Debt to equity: 0.24129293282280392
Current ratio: 3.164868660678458
Quick ratio: 1.3761690897305305
Interest coverage ratio: -5.932326283987916
COGS to revenue (%): 90.73763364610637
R&D to revenue (%): 2.4361263417372623
SG&A to revenue (%): 10.093367607518372
Free cash flow (dilution-adjusted): -23011000
Buyback yield (%): 0
Retained earnings: 131070000
Inventory turnover: 3.7096603018197194
Receivables turnover: 13.439203562413137
Capitalized R&D asset: 45181650
ROCI (R&D-adjusted, %): -4.460829357813554
Rosenberg metric: -0.6759492571031367
FCF margin (%): -2.428212044083693
Revenue growth (%): 11.614529350796193
Rule of 40 score: 9.1863173067125
Financial ratios for ICHR — quarterly report dated 2025-12-31
Total revenue: 223606000
Gross profit: 20982000
Operating income: -13835000
Net income: -15961000
Capital expenditures: 3249000
Operating cash flow: 9170000
Depreciation & amortization: 10044000
Net tangible assets: 288078000
Owner earnings: -9166000
Return on net tangible assets (%): -3.181777157575379
Buffett classification: The Gruesome
Stock price: 18.43
Shares outstanding: 34867053
Book value: 663886000
P/B ratio: 0.9679369451833598
Market cap (USD): 642599786.79
Debt to equity: 0.24129293282280392
Current ratio: 3.164868660678458
Quick ratio: 1.3761690897305305
Interest coverage ratio: -8.205812574139976
COGS to revenue (%): 90.61653086232033
R&D to revenue (%): 2.5061939303954275
SG&A to revenue (%): 12.135184207937174
Free cash flow (dilution-adjusted): 1764000
Buyback yield (%): 0
Retained earnings: 131070000
Inventory turnover: 0.8741555001423678
Receivables turnover: 3.171086592733358
Capitalized R&D asset: 11439960
ROCI (R&D-adjusted, %): -1.6936836387630376
Rosenberg metric: 1.6807392336385216
FCF margin (%): 0.7888875969338927
Revenue growth (%): -6.556733083712222
Rule of 40 score: -5.76784548677833
Financial ratios for IMPN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.208791208791208
Shares outstanding: 18464458
Market cap (USD): 391608834.5054945
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMPN.SW — annual report dated 2022-12-31
Total revenue: 3846026086.9565215
Gross profit: 1535415217.3913043
Operating income: 109441304.34782608
Net income: 115177173.91304347
Capital expenditures: 18593478.260869563
Operating cash flow: 139267391.3043478
Depreciation & amortization: 102404347.82608695
Net tangible assets: 256068478.26086956
Owner earnings: 198988043.47826087
Return on net tangible assets (%): 77.70891787607765
Capex to operating income (%): 16.98945235683213
Buffett classification: The Great
Stock price: 38.45652173913044
P/E ratio: 6.165100308975775
Shares outstanding: 18464458
Book value: 524641304.347826
P/B ratio: 1.3534558270453936
Market cap (USD): 710078830.4782609
Debt to equity: 0
Current ratio: 1.146610867050289
Quick ratio: 1.0067155788303956
Effective tax rate (%): 13.97920167555588
Interest coverage ratio: 5.189732488016082
COGS to revenue (%): 60.077878239085855
SG&A to revenue (%): 2.229319704358875
Free cash flow (dilution-adjusted): 97185869.56521739
Buyback yield (%): 0.8086977188828657
Retained earnings: 428234782.6086956
Inventory turnover: 9.497046918698679
Receivables turnover: 6.225872689938398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.729381879028795
FCF margin (%): 2.526916546271363
Rule of 40 score: 2.526916546271363
Financial ratios for IMPN.SW — annual report dated 2023-12-31
Total revenue: 4280844047.6190476
Gross profit: 1782538095.2380953
Operating income: 125615476.1904762
Net income: 168758333.33333334
Capital expenditures: 34975000
Operating cash flow: -36155952.38095238
Depreciation & amortization: 123552380.95238096
Net tangible assets: 178182142.85714287
Owner earnings: 257335714.28571427
Return on net tangible assets (%): 144.42284179511333
Capex to operating income (%): 27.84290683017902
Buffett classification: The Good
Stock price: 34.142857142857146
P/E ratio: 3.7356931611137374
Shares outstanding: 18464458
Book value: 685446428.5714288
P/B ratio: 0.9197354095610262
Market cap (USD): 630429351.7142857
Debt to equity: 0
Current ratio: 0.9957982878886512
Quick ratio: 0.8651590002687944
Effective tax rate (%): -27.514864755462405
Interest coverage ratio: 6.593988251468566
COGS to revenue (%): 58.36012535356151
SG&A to revenue (%): 2.407374602638721
Free cash flow (dilution-adjusted): -107308333.33333334
Buyback yield (%): 3.173385301073227
Retained earnings: 615717857.1428572
Inventory turnover: 9.246013807931408
Receivables turnover: 6.81256263794557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.032798757698043
FCF margin (%): -2.506709708171147
Revenue growth (%): 11.305642521177253
Rule of 40 score: 8.798932813006106
Financial ratios for IMPN.SW — annual report dated 2024-12-31
Total revenue: 3954346666.6666665
Gross profit: 1728745555.5555556
Operating income: 92385555.55555555
Net income: 103723333.33333333
Capital expenditures: 21653333.333333332
Operating cash flow: 47953333.333333336
Depreciation & amortization: 130467777.77777778
Net tangible assets: 240847777.77777776
Owner earnings: 212537777.77777776
Return on net tangible assets (%): 88.24568768655166
Capex to operating income (%): 23.438007384511767
Buffett classification: The Great
Stock price: 32.67777777777778
P/E ratio: 5.817181495431222
Shares outstanding: 18464458
Book value: 729632222.2222223
P/B ratio: 0.8269610866052759
Market cap (USD): 603377455.3111111
Debt to equity: 0
Current ratio: 1.0008580243048517
Quick ratio: 0.8555271728921627
Effective tax rate (%): 12.269044978666619
Interest coverage ratio: 4.144295469271794
COGS to revenue (%): 56.28239754172062
SG&A to revenue (%): 3.4113234606531435
Free cash flow (dilution-adjusted): -41708888.88888889
Buyback yield (%): 0.08213027371068068
Retained earnings: 682452222.2222222
Inventory turnover: 7.313438121839458
Receivables turnover: 6.551656087539212
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.849750673260457
FCF margin (%): -1.054760556035103
Revenue growth (%): -7.626939391402845
Rule of 40 score: -8.681699947437949
Financial ratios for IMPN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 240847777.77777776
Buffett classification: The Gruesome
Stock price: 32.67777777777778
Shares outstanding: 18464458
Book value: 729632222.2222223
P/B ratio: 0.8269610866052759
Market cap (USD): 603377455.3111111
Debt to equity: 0
Current ratio: 1.0008580243048517
Quick ratio: 0.8555271728921627
Buyback yield (%): 0
Retained earnings: 682452222.2222222
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMPN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 275717500
Buffett classification: The Gruesome
Stock price: 67.87499999999999
Shares outstanding: 18464458
Book value: 826243750
P/B ratio: 1.5168345742403495
Market cap (USD): 1253275086.7499998
Debt to equity: 0
Current ratio: 1.0575263050871786
Quick ratio: 0.9350322160067303
Buyback yield (%): 0
Retained earnings: 41230000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCH.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08405405405405406
Shares outstanding: 54410664
Market cap (USD): 4573436.892972973
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCH.L — annual report dated 2022-12-31
Total revenue: -41598795.18072289
Net income: -42467469.87951808
Capital expenditures: 0
Operating cash flow: 24560240.963855423
Net tangible assets: 500963855.42168677
Owner earnings: -42467469.87951808
Return on net tangible assets (%): -8.477152477152478
Buffett classification: The Gruesome
Stock price: 0.07108433734939759
Shares outstanding: 54410664
Book value: 500963855.4216867
P/B ratio: 0.007720608888888889
Market cap (USD): 3867745.995180723
Debt to equity: 0.09620009620009622
Free cash flow (dilution-adjusted): 24560240.963855423
Buyback yield (%): 0
Receivables turnover: -32.82034220532319
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCH.L — annual report dated 2023-12-31
Total revenue: 36840506.32911392
Net income: 35716455.69620253
Capital expenditures: 0
Operating cash flow: 22603797.46835443
Net tangible assets: 516198734.17721516
Owner earnings: 35716455.69620253
Return on net tangible assets (%): 6.919128880300739
Buffett classification: The Gruesome
Stock price: 0.07683544303797468
P/E ratio: 0.11705157728948114
Shares outstanding: 54410664
Book value: 516198734.1772151
P/B ratio: 0.008098949489084031
Market cap (USD): 4180667.4744303795
Debt to equity: 0.09808801928410461
Effective tax rate (%): 0.06021322565791804
COGS to revenue (%): 0
SG&A to revenue (%): 2.9789719626168227
Free cash flow (dilution-adjusted): 22603797.46835443
Buyback yield (%): 468.824658260354
Receivables turnover: 27.048327137546465
Capitalized R&D asset: 0
FCF margin (%): 61.35582737768005
Rule of 40 score: 61.35582737768005
Financial ratios for JCH.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 512118750
Buffett classification: The Gruesome
Stock price: 0.082125
Shares outstanding: 54410664
Book value: 512118750
P/B ratio: 0.008725468030608136
Market cap (USD): 4468475.781
Debt to equity: 0.09763360548700863
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCH.L — annual report dated 2024-12-31
Total revenue: 42765000
Net income: 41741250
Capital expenditures: 0
Operating cash flow: 21863750
Net tangible assets: 512118750
Owner earnings: 41741250
Return on net tangible assets (%): 8.150697470069197
Buffett classification: The Gruesome
Stock price: 0.082125
P/E ratio: 0.1070517960291079
Shares outstanding: 54410664
Book value: 512118750
P/B ratio: 0.008725468030608136
Market cap (USD): 4468475.781
Debt to equity: 0.09763360548700863
Effective tax rate (%): 0.020958083832335328
COGS to revenue (%): 0
SG&A to revenue (%): 2.3412837600841807
Free cash flow (dilution-adjusted): 21863750
Buyback yield (%): 332.32808518605685
Receivables turnover: 36.39574468085107
Capitalized R&D asset: 0
FCF margin (%): 51.125336139366304
Revenue growth (%): 16.081466465090713
Rule of 40 score: 67.20680260445701
Financial ratios for JCH.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 613197260.2739726
Buffett classification: The Gruesome
Stock price: 0.10315068493150686
Shares outstanding: 54410664
Book value: 613197260.2739726
P/B ratio: 0.009152841382021921
Market cap (USD): 5612497.259178083
Debt to equity: 0.08935871716625636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JMA.NS — annual report dated 2022-03-31
Total revenue: 57562073.0581564
Gross profit: 8284860.873005407
Operating income: 3762481.867334828
Net income: 3232612.422524067
Capital expenditures: 53725.43848081234
Operating cash flow: 1526836.3444547013
Depreciation & amortization: 89740.20836080707
Net tangible assets: 24020545.95806409
Owner earnings: 3268627.192404062
Return on net tangible assets (%): 13.607630726256371
Capex to operating income (%): 1.4279255123392534
Buffett classification: The Great
Stock price: 0.779506791507319
P/E ratio: 5.5078538318191645
Shares outstanding: 22841054
Book value: 24252868.257945403
P/B ratio: 0.7341299399650372
Market cap (USD): 17804756.718185417
Debt to equity: 0
Current ratio: 2.775085418196194
Quick ratio: 1.975412266335348
Effective tax rate (%): 25.643001228519864
COGS to revenue (%): 85.60708391333473
SG&A to revenue (%): 0.06231483102142255
Free cash flow (dilution-adjusted): 1431570.6184887248
Buyback yield (%): 0
Retained earnings: 3796703.1517868917
Inventory turnover: 5.497793785522702
Receivables turnover: 5.716883470680378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.390769174335286
FCF margin (%): 2.487003233956451
Rule of 40 score: 2.487003233956451
Financial ratios for JMA.NS — annual report dated 2023-03-31
Total revenue: 61107344.70158344
Gross profit: 8615931.790499391
Operating income: 3866163.2155907433
Net income: 3336224.116930573
Capital expenditures: 549317.9049939099
Operating cash flow: 310998.7819732034
Depreciation & amortization: 111096.22411693058
Net tangible assets: 24960755.176613886
Owner earnings: 2898002.4360535936
Return on net tangible assets (%): 11.610235409739431
Capex to operating income (%): 14.208347510491096
Buffett classification: The Great
Stock price: 0.6845310596833131
P/E ratio: 4.686558921373912
Shares outstanding: 22841054
Book value: 25216552.984165654
P/B ratio: 0.6200455275834802
Market cap (USD): 15635410.898903776
Debt to equity: 0
Current ratio: 2.904781029974673
Quick ratio: 1.9486944700423057
Effective tax rate (%): 25.53334366444548
COGS to revenue (%): 85.90033353179535
SG&A to revenue (%): 0.056867639522551014
Free cash flow (dilution-adjusted): -268331.30328867235
Buyback yield (%): 0
Retained earnings: 4434165.651644336
Inventory turnover: 5.277954680729636
Receivables turnover: 6.037962678798164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.216197014976887
FCF margin (%): -0.4391146507822639
Revenue growth (%): 6.159040936286572
Rule of 40 score: 5.719926285504308
Financial ratios for JMA.NS — annual report dated 2024-03-31
Total revenue: 63807291.04209138
Gross profit: 8669876.483990885
Operating income: 3420326.1781988246
Net income: 3118563.3769037053
Capital expenditures: 105084.54251109246
Operating cash flow: 1431454.610864612
Depreciation & amortization: 131382.6597913419
Net tangible assets: 27254898.668905143
Owner earnings: 3144861.494183955
Return on net tangible assets (%): 11.538701839944455
Capex to operating income (%): 3.0723544199059676
Buffett classification: The Great
Stock price: 1.1309980806142035
P/E ratio: 8.283682295677472
Shares outstanding: 22841054
Book value: 27575272.81448615
P/B ratio: 0.9368243936152246
Market cap (USD): 25833188.233205374
Debt to equity: 0
Current ratio: 3.1517693018328345
Quick ratio: 2.1887412937990094
Effective tax rate (%): 25.432326030170348
COGS to revenue (%): 86.41240469169632
SG&A to revenue (%): 0.29309006575967556
Free cash flow (dilution-adjusted): 1321309.5095335173
Buyback yield (%): 0
Retained earnings: 5682779.709797338
Inventory turnover: 5.017913366706719
Receivables turnover: 5.828161522604446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.333449077026923
FCF margin (%): 2.070781391834825
Revenue growth (%): 4.418366325182474
Rule of 40 score: 6.489147717017298
Financial ratios for JMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 27777603.91782131
Buffett classification: The Gruesome
Stock price: 1.248924988055423
Shares outstanding: 22841054
Book value: 28109627.32919254
P/B ratio: 1.0148396049526252
Market cap (USD): 28526763.09412327
Debt to equity: 0
Current ratio: 3.8114365125804563
Quick ratio: 2.553474253949678
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JMA.NS — quarterly report dated 2024-12-31
Total revenue: 16440890.546683762
Gross profit: 2230656.2536426154
Operating income: 847791.1178459027
Net income: 794101.8766756032
Capital expenditures: 0
Depreciation & amortization: 32334.770952325445
Owner earnings: 826436.6476279286
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.1016435481990907
P/E ratio: 7.921747987332296
Shares outstanding: 22841054
Market cap (USD): 25162699.773167033
Effective tax rate (%): 25.89039009638188
COGS to revenue (%): 86.43226626131542
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JMA.NS — quarterly report dated 2025-03-31
Total revenue: 18588636.895019874
Gross profit: 2697299.5090016364
Operating income: 1309492.63502455
Net income: 1172808.0430208088
Capital expenditures: 0
Depreciation & amortization: 29833.995791442598
Net tangible assets: 29054126.72433949
Owner earnings: 1202642.0388122515
Return on net tangible assets (%): 4.139315733777547
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8491072470533318
P/E ratio: 4.134202650883505
Shares outstanding: 22841054
Book value: 29405880.289922845
P/B ratio: 0.6595451076627974
Market cap (USD): 19394504.481736492
Debt to equity: 0
Current ratio: 3.3968432501780965
Quick ratio: 2.267999725082612
Effective tax rate (%): 25.38174894196226
COGS to revenue (%): 85.48952500264137
Buyback yield (%): 0
Retained earnings: 6272328.735094692
Inventory turnover: 1.313704285706002
Receivables turnover: 1.643172771276574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.427968136845064
Revenue growth (%): 13.063442897071816
Rule of 40 score: 13.063442897071816
Financial ratios for JMA.NS — annual report dated 2025-03-31
Total revenue: 64965852.23287351
Gross profit: 8951882.160392798
Operating income: 3241512.742576572
Net income: 3063853.168108487
Capital expenditures: 39139.583820434884
Operating cash flow: -234521.8611176058
Depreciation & amortization: 121837.73673135374
Net tangible assets: 29054126.72433949
Owner earnings: 3146551.321019406
Return on net tangible assets (%): 10.82996350526498
Capex to operating income (%): 1.2074480937972225
Buffett classification: The Great
Stock price: 0.8491072470533318
P/E ratio: 6.330102461701833
Shares outstanding: 22841054
Book value: 29405880.289922845
P/B ratio: 0.6595451076627974
Market cap (USD): 19394504.481736492
Debt to equity: 0
Current ratio: 3.3968432501780965
Quick ratio: 2.267999725082612
Effective tax rate (%): 26.407714101991704
COGS to revenue (%): 86.22063460615539
SG&A to revenue (%): 0.30628849637558914
Free cash flow (dilution-adjusted): -274748.65559971944
Buyback yield (%): 0
Retained earnings: 6272328.735094692
Inventory turnover: 4.63056008164354
Receivables turnover: 5.742762100024389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.960974315855717
FCF margin (%): -0.4229124165336406
Revenue growth (%): 1.8157191315611072
Rule of 40 score: 1.3928067150274666
Financial ratios for JMA.NS — quarterly report dated 2025-06-30
Total revenue: 16269131.757547392
Gross profit: 2133278.7268897733
Operating income: 603756.1432249006
Net income: 657406.9740229348
Capital expenditures: 0
Depreciation & amortization: 27100.39784694594
Owner earnings: 684507.3718698807
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.1505967704189095
P/E ratio: 10.014355746541362
Shares outstanding: 22841054
Market cap (USD): 26280842.965363916
Effective tax rate (%): 26.187035236618755
COGS to revenue (%): 86.88756868724647
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.478080832779655
Rule of 40 score: -12.478080832779655
Financial ratios for JMA.NS — quarterly report dated 2025-09-30
Total revenue: 15969165.727170236
Gross profit: 2160405.8624577224
Operating income: 684464.4870349492
Net income: 673788.0496054115
Capital expenditures: 0
Depreciation & amortization: 27914.31792559188
Net tangible assets: 28882931.22886133
Owner earnings: 701702.3675310033
Return on net tangible assets (%): 2.4294707554814443
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.021758737316798
P/E ratio: 7.076198876345684
Shares outstanding: 22841054
Book value: 29234340.473506197
P/B ratio: 0.7983093210252186
Market cap (USD): 23338046.4940248
Debt to equity: 0
Current ratio: 4.3144282924082855
Quick ratio: 2.970924883841741
Effective tax rate (%): 26.39325081593694
COGS to revenue (%): 86.47139180989294
Buyback yield (%): 0
Inventory turnover: 1.322903863393349
Receivables turnover: 1.7384610097682691
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.32485115469037
Revenue growth (%): -1.843774055354849
Rule of 40 score: -1.843774055354849
Financial ratios for JMA.NS — quarterly report dated 2025-12-31
Total revenue: 18780160.409936506
Gross profit: 2558159.741561769
Operating income: 1100835.4684192939
Net income: 995020.6082210093
Capital expenditures: 0
Depreciation & amortization: 28639.857413389775
Owner earnings: 1023660.465634399
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8773532360476775
P/E ratio: 5.727218362528897
Shares outstanding: 22841054
Market cap (USD): 20039672.641639747
Effective tax rate (%): 25.410636894274045
COGS to revenue (%): 86.37839248589027
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 17.60263955419782
Rule of 40 score: 17.60263955419782
Financial ratios for KF — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.48
Shares outstanding: 4158348
Market cap (USD): 122588099.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KF — annual report dated 2022-06-30
Total revenue: -81960952
Net income: -83884647
Capital expenditures: 0
Net tangible assets: 142799749
Owner earnings: -83884647
Return on net tangible assets (%): -58.742853252494164
Buffett classification: The Gruesome
Stock price: 19.8
Shares outstanding: 4158348
Book value: 142799749
P/B ratio: 0.576578677319664
Market cap (USD): 82335290.4
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 16048097
Receivables turnover: -138.46790322226408
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KF — annual report dated 2023-06-30
Total revenue: 7761130
Net income: 6155562
Capital expenditures: 0
Net tangible assets: 130718188
Owner earnings: 6155562
Return on net tangible assets (%): 4.709032533406905
Buffett classification: The Gruesome
Stock price: 21.73
P/E ratio: 14.679553554980034
Shares outstanding: 4158348
Book value: 130718188
P/B ratio: 0.6912649526628996
Market cap (USD): 90360902.04
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 12.599930680197344
Buyback yield (%): 0
Retained earnings: 5802986
Receivables turnover: 7.760516919163386
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KF — annual report dated 2024-06-30
Total revenue: 11970465
Net income: 10516434
Capital expenditures: 0
Net tangible assets: 139119930
Owner earnings: 10516434
Return on net tangible assets (%): 7.559257685077904
Buffett classification: The Gruesome
Stock price: 22.66
P/E ratio: 8.960087200661365
Shares outstanding: 4158348
Book value: 139119930
P/B ratio: 0.6773160803056759
Market cap (USD): 94228165.68
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 7.873094320061918
Buyback yield (%): 0
Retained earnings: 16319420
Receivables turnover: 11.622318450806103
Capitalized R&D asset: 0
Revenue growth (%): 54.236109947907075
Rule of 40 score: 54.236109947907075
Financial ratios for KF — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 90927992
Buffett classification: The Gruesome
Stock price: 17.73
Shares outstanding: 4158348
Book value: 90927992
P/B ratio: 0.8108340283155049
Market cap (USD): 73727510.04
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -14683689
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KF — annual report dated 2025-06-30
Total revenue: 10175359
Net income: 8602095
Capital expenditures: 0
Net tangible assets: 128356812
Owner earnings: 8602095
Return on net tangible assets (%): 6.7017050875336475
Buffett classification: The Gruesome
Stock price: 25.9
P/E ratio: 12.520346868989472
Shares outstanding: 4158348
Book value: 128356812
P/B ratio: 0.8390767230959273
Market cap (USD): 107701213.19999999
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 10.423730504250514
Buyback yield (%): 0
Retained earnings: 23026196
Receivables turnover: 6.142615327684138
Capitalized R&D asset: 0
Revenue growth (%): -14.996125881492489
Rule of 40 score: -14.996125881492489
Financial ratios for KF — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 128356812
Buffett classification: The Gruesome
Stock price: 25.9
Shares outstanding: 4158348
Book value: 128356812
P/B ratio: 0.8390767230959273
Market cap (USD): 107701213.19999999
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 23026196
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVX.V — annual report dated 2021-06-30
Total revenue: 0
Gross profit: -12397.58064516129
Operating income: -4000150
Net income: -4002145.9677419355
Capital expenditures: 779981.4516129033
Operating cash flow: -2277487.9032258065
Depreciation & amortization: 12397.58064516129
Net tangible assets: 7164750.806451613
Owner earnings: -4769729.838709678
Return on net tangible assets (%): -66.57216653529247
Buffett classification: The Gruesome
Stock price: 1.532258064516129
Shares outstanding: 116257264
Book value: 7164750.806451613
P/B ratio: 24.86285080036212
Market cap (USD): 178136130.32258064
Debt to equity: 0
Current ratio: 18.941602746302838
Quick ratio: 18.941602746302838
Free cash flow (dilution-adjusted): -4594133.064516129
Buyback yield (%): 0
Retained earnings: -4002145.9677419355
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.83097176803417
Rule of 40 score: 0
Financial ratios for LVX.V — annual report dated 2022-06-30
Total revenue: 0
Gross profit: -52962.01550387597
Operating income: -2847051.1627906975
Net income: -2832139.534883721
Capital expenditures: 15312.403100775193
Operating cash flow: -2408512.403100775
Depreciation & amortization: 52962.01550387597
Net tangible assets: 4521846.511627907
Owner earnings: -2794489.92248062
Return on net tangible assets (%): -61.79975183356186
Buffett classification: The Gruesome
Stock price: 0.19379844961240308
Shares outstanding: 116257264
Book value: 4521846.511627907
P/B ratio: 4.982583433878799
Market cap (USD): 22530477.519379843
Debt to equity: 0
Current ratio: 41.09716358733165
Quick ratio: 41.09716358733165
Free cash flow (dilution-adjusted): -2948980.6201550383
Buyback yield (%): 0
Retained earnings: -6679163.565891473
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -62.96213627484965
Rule of 40 score: 0
Financial ratios for LVX.V — annual report dated 2023-06-30
Total revenue: 0
Gross profit: -31460.150375939847
Operating income: -1148517.2932330826
Net income: -1009743.6090225563
Capital expenditures: 121303.75939849623
Operating cash flow: -948348.872180451
Depreciation & amortization: 31460.150375939847
Net tangible assets: 3376845.864661654
Owner earnings: -1099587.2180451127
Return on net tangible assets (%): -32.562552811550574
Buffett classification: The Gruesome
Stock price: 0.11278195488721804
Shares outstanding: 116257264
Book value: 3376845.8646616535
P/B ratio: 3.8828309106353425
Market cap (USD): 13111721.503759397
Debt to equity: 0
Current ratio: 21.585885413843567
Quick ratio: 21.585885413843567
Free cash flow (dilution-adjusted): -951762.4060150376
Buyback yield (%): 0
Retained earnings: -7488030.07518797
Receivables turnover: 0
Capitalized R&D asset: 102239.84962406014
ROCI (R&D-adjusted, %): -31.05291108659897
Rule of 40 score: 0